Nakamaru, R.; Ikemura, N.; Kimura, T.; Katsumata, Y.; Sherrod, C.F.; Miyama, H.; Shiraishi, Y.; Kanki, H.; Negishi, K.; Ueda, I.;
et al. Discontinuation of Oral Anticoagulants in Atrial Fibrillation Patients: Impact of Treatment Strategy and on Patients’ Health Status. J. Clin. Med. 2023, 12, 7712.
https://doi.org/10.3390/jcm12247712
AMA Style
Nakamaru R, Ikemura N, Kimura T, Katsumata Y, Sherrod CF, Miyama H, Shiraishi Y, Kanki H, Negishi K, Ueda I,
et al. Discontinuation of Oral Anticoagulants in Atrial Fibrillation Patients: Impact of Treatment Strategy and on Patients’ Health Status. Journal of Clinical Medicine. 2023; 12(24):7712.
https://doi.org/10.3390/jcm12247712
Chicago/Turabian Style
Nakamaru, Ryo, Nobuhiro Ikemura, Takehiro Kimura, Yoshinori Katsumata, Charles F. Sherrod, Hiroshi Miyama, Yasuyuki Shiraishi, Hideaki Kanki, Koji Negishi, Ikuko Ueda,
and et al. 2023. "Discontinuation of Oral Anticoagulants in Atrial Fibrillation Patients: Impact of Treatment Strategy and on Patients’ Health Status" Journal of Clinical Medicine 12, no. 24: 7712.
https://doi.org/10.3390/jcm12247712
APA Style
Nakamaru, R., Ikemura, N., Kimura, T., Katsumata, Y., Sherrod, C. F., Miyama, H., Shiraishi, Y., Kanki, H., Negishi, K., Ueda, I., Fukuda, K., Takatsuki, S., & Kohsaka, S.
(2023). Discontinuation of Oral Anticoagulants in Atrial Fibrillation Patients: Impact of Treatment Strategy and on Patients’ Health Status. Journal of Clinical Medicine, 12(24), 7712.
https://doi.org/10.3390/jcm12247712
